Bilaketaren emaitzak - Michelle Melisko

Findu emaitzak
  1. 1
    SIS.NET: A randomized controlled trial evaluating a web‐based system for symptom management after treatment of breast cancer

    SIS.NET: A randomized controlled trial evaluating a web‐based system for symptom management after treatment of breast cancer nork Alyse Wheelock, Meredith Bock, Eva L. Martin, Jimmy Hwang, Mary Lou Ernest, Hope S. Rugo, Laura J. Esserman, Michelle Melisko

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer

    Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer nork Joseph M. Letourneau, E. Ebbel, Patricia Katz, A. Katz, Wei Z. Ai, A. Jo Chien, Michelle Melisko, Marcelle I. Cedars, Mitchell P. Rosen

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    A randomized pilot trial of a positive affect skill intervention (lessons in linking affect and coping) for women with metastatic breast cancer

    A randomized pilot trial of a positive affect skill intervention (lessons in linking affect and coping) for women with metastatic breast cancer nork Elaine O. Cheung, Michael Cohn, Laura B. Dunn, Michelle Melisko, Stefana Morgan, Frank J. Penedo, John M. Salsman, Dianne M. Shumay, Judith T. Moskowitz

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

    A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer nork Pamela N. Münster, Kenneth T. Thurn, Scott Thomas, Paromita Raha, M. Lacevic, Alexandra Miller, Michelle Melisko, Roohi Ismail‐Khan, Hope S. Rugo, Mark M. Moasser, Susan Minton

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer

    Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer nork Joseph M. Letourneau, E. Ebbel, Patricia Katz, Kutluk Oktay, Charles E. McCulloch, Wei Z. Ai, A. Jo Chien, Michelle Melisko, Marcelle I. Cedars, Mitchell P. Rosen

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu

    A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu nork Prema P. Peethambaram, Michelle Melisko, Kristine Rinn, Steven R. Alberts, Nicole Provost, Lori Jones, Robert B. Sims, Lisa R. C. Lin, Mark W. Frohlich, John W. Park

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

    Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis nork Mark Jesus M. Magbanua, Michelle Melisko, Ritu Roy, Eduardo V. Sosa, Louai Hauranieh, Andrea Kablanian, Lauren E. Eisenbud, Artem Ryazantsev, Alfred Au, Janet H. Scott, John W. Park

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    GLORIA: phase III, Open-Label Study of Adagloxad Simolenin/OBI-821 in Patients with High-Risk Triple-Negative Breast Cancer

    GLORIA: phase III, Open-Label Study of Adagloxad Simolenin/OBI-821 in Patients with High-Risk Triple-Negative Breast Cancer nork Hope S. Rugo, Javier Cortés, Carlos H. Barrios, Paula Cabrera, Binghe Xu, Chiun‐Sheng Huang, Sung‐Bae Kim, Michelle Melisko, Rita Nanda, Tadeusz Pieńkowski, Bernardo L. Rapoport, Richard B. Schwab

    Argitaratua 2022
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

    Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer nork Manuela Terranova-Barberio, Nela Pawłowska, Mallika Dhawan, Mark M. Moasser, A. Jo Chien, Michelle Melisko, Hope S. Rugo, Roshun Rahimi, Travis Deal, Adil Daud, Michael D. Rosenblum, Scott Thomas, Pamela N. Münster

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer nork Hope S. Rugo, Paula Klein, Susan A. Melin, Sara A. Hurvitz, Michelle Melisko, Anne Moore, Glen Park, Jules T. Mitchel, Erika Bågeman, Ralph B. D’Agostino, Elizabeth S. Ver Hoeve, Laura J. Esserman, Tessa Cigler

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy

    Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy nork Christine Miaskowski, Bruce A. Cooper, Michelle Melisko, Lee-may Chen, Judy Mastick, Claudia West, Steven M. Paul, Laura B. Dunn, Brian L. Schmidt, Marilyn J. Hammer, Frances Cartwright, Fay Wright, Dale J. Langford, Kathryn Lee, Bradley E. Aouizerat

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue

    Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue nork Fay Wright, Gail DʼEramo Melkus, Marilyn J. Hammer, Brian L. Schmidt, M. Tish Knobf, Steven M. Paul, Frances Cartwright, Judy Mastick, Bruce A. Cooper, Lee-may Chen, Michelle Melisko, Jon D. Levine, Kord M. Kober, Bradley E. Aouizerat, Christine Miaskowski

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Fully Automated Echocardiogram Interpretation in Clinical Practice

    Fully Automated Echocardiogram Interpretation in Clinical Practice nork Jeffrey Zhang, Sravani Gajjala, Pulkit Agrawal, Geoffrey H. Tison, Laura A. Hallock, Lauren Beussink‐Nelson, Mats Christian Højbjerg Lassen, Eugene Fan, Mandar A. Aras, ChaRandle Jordan, Kirsten E. Fleischmann, Michelle Melisko, Atif Qasim, Sanjiv J. Shah, Ruzena Bajcsy, Rahul C. Deo

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

    Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer nork Rachna Malani, Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D. Groves, Nancy U. Lin, Michelle Melisko, Andrew B. Lassman, Suriya Jeyapalan, Andrew D. Seidman, Anna Skakodub, Adrienne Boire, Lisa M. DeAngelis, Marc K. Rosenblum, Jeffrey J. Raizer, Elena Pentsova

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

    Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study nork Linda T. Vahdat, Peter Schmid, Andres Forero‐Torres, Kimberly Blackwell, Melinda L. Telli, Michelle Melisko, Volker Möbus, Javier Cortés, Alberto J. Montero, X. Cynthia, Rita Nanda, Gail S. Wright, Yi He, Thomas Hawthorne, Rebecca G. Bagley, Abdel‐Baset Halim, Christopher D. Turner, Denise A. Yardley

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

    EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer nork Denise A. Yardley, Robert Weaver, Michelle Melisko, Mansoor N. Saleh, Francis P. Arena, Andres Forero, Tessa Cigler, Alison Stopeck, Dennis L. Citrin, Ira A. Oliff, Rebecca Bechhold, Randa Loutfi, Agustin A. García, Scott Cruickshank, Elizabeth Crowley, Jennifer Green, Thomas Hawthorne, Michael Yellin, Thomas A. Davis, Linda T. Vahdat

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics

    A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cere... nork Priya Kumthekar, Michael J. Avram, Andrew B. Lassman, Nancy U. Lin, Eudocia Q. Lee, Sean Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V. Lukas, Karan Dixit, Isabella Perron, Hui Zhang, William J. Gradishar, Elena Pentsova, Suriya Jeyapalan, Morris D. Groves, Michelle Melisko, Jeffrey J. Raizer

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

    Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with H... nork Laura A. Huppert, Reshma Mahtani, Samantha Fisch, Naomi Dempsey, Sarah Premji, A. Jay Raimonde, Saya Jacob, Laura Quintal, Michelle Melisko, Jo Chien, Ana Sandoval, Lauren Carcas, Manmeet S. Ahluwalia, Natasha Harpalani, Jenna Hoppenworth, Anne Blaes, Kelly Blum, Mi‐Ok Kim, Damé Idossa, Ruta Rao, Karthik V. Giridhar, Hope S. Rugo

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial

    Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial nork Claire F. Friedman, Anishka D'souza, Diana Bello Roufai, Anna V. Tinker, Maria J. de Miguel, Valentina Gambardella, Jonathan W. Goldman, Sherene Loi, Michelle Melisko, Ana Oaknin, Iben Spanggaard, Geoffrey I. Shapiro, Adam C. ElNaggar, Stefano Panni, Vignesh Ravichandran, Aimee Frazier, Daniel DiPrimeo, Lisa D. Eli, David B. Solit

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

    TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases nork Carey K. Anders, Allison M. Deal, Vandana G. Abramson, Minetta C. Liu, Anna Maria Storniolo, John T. Carpenter, Shannon Puhalla, Rita Nanda, Amal Melhem‐Bertrandt, Nancy U. Lin, P. Kelly Marcom, Catherine Van Poznak, Vered Stearns, Michelle Melisko, J. Keith Smith, Olga Karginova, Joel S. Parker, Jonathan S. Berg, Eric P. Winer, Amy H. Peterman, Aleix Prat, Charles M. Perou, Antonio C. Wolff, Lisa A. Carey

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: